The redirection of healthcare and life sciences resources to COVID-19 has taken focus from other areas of need, including antimicrobial resistance.
Jamie Culp
Advertisement
Articles by Jamie Culp
Advertisement
Latest Updated Articles
COVID and AMR: Crisis Reframes Antibiotics FightDecember 11th 2020
Advertisement
Advertisement
Trending on PharmExec
1
Pharmaceutical Executive Daily: Mike Doustdar Open to Direct Listing for Novo Shares
2
Shaping the Future of Market Access: Q&A with Jen Norton
3
Nine European Drugmakers Warn the Continent Risks Losing the Pharma Investment Race: Report
4
Novo CEO Considering Direct Shares Listing: Report
5